Last updated: about 1 month ago
AstraZeneca's Imfinzi: Groundbreaking EU Approval for Bladder Cancer Treatment
AstraZeneca announces EU approval of Imfinzi for muscle-invasive bladder cancer, showing significant survival benefits and addressing critical treatment needs.